New!
Ph 2 Prostate Cancer Results Strong Safety and 40% Response
Invion's Phase II prostate cancer trial shows strong safety and 40% positive response rate.
Invion
Prostate Cancer
Clinical Trial
Stock Market News
Biotechnology
Posted on: 17/09/2024
Read More